Exam 33: Targeted Therapies to Treat Cancer

The nurse is preparing to administer intravenous temsirolimus (Torisel). To prevent a common adverse drug effect, the nurse will expect to administer which type of drug?

A patient who has metastatic colorectal cancer tells the nurse that a cousin who had colorectal cancer received bevacizumab (Avastin) and wonders how the drug works. The nurse will explain that bevacizumab works by targeting which of the following?

The nurse performs a medication history on a patient who will begin targeted therapy for cancer with gefitinib (Iressa). The nurse learns that the patient is taking carbamazepine, a histamine₂ blocker, and warfarin. The nurse will anticipate that the provider will make which change to the medication regimen?

Which of the following agents is NOT an epidermal growth factor receptor (EGFR) inhibitor?

A patient who is taking the tyrosine kinase inhibitor sunitinib (Sutent) calls to report red, painful, and swollen palms and soles of feet. The nurse will perform which action?

The nurse is performing a history on a patient who will begin taking bevacizumab (Avastin). Which aspect of the patient's history should be reported to the oncologist treating this patient?

What action is most important for the nurse to teach the patient taking imatinib?

The patient asks the nurse what apoptosis means. The nurse will explain that apoptosis refers to:

The nurse is teaching a patient who will begin receiving targeted therapy for cancer. The patient asks how targeted therapy differs from other types of chemotherapies. The nurse will explain that targeted therapy: